IL2 and type 1 diabetes mellitus: Studies in non-obese diabetic (NOD) mice could demonstrate that a local deficiency of IL-2 in pancreatic islets contributes to the development of type-1 diabetes (T1D), which could be prevented by low-dose administration of IL-2/anti-IL-2 complexes (26).